Organogenesis Holdings (ORGO) Earnings Analysis
Organogenesis Holdings (ORGO) next reports earnings on 2026-08-06, consensus EPS -0.35 USD. Last quarter (2026-05-07) it missed with EPS -0.37 USD vs -0.29 USD est (-27.6%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -16.89.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ORGO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.35 USD |
| Revenue estimate | 0.05B |
ORGO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.37 USD | -0.29 USD | -27.6% | Miss |
| 2026-02-26 | 0.31 USD | 0.215 USD | +44.2% | Beat |
| 2025-11-06 | 0.18 USD | 0.21 USD | -14.3% | Miss |
| 2025-02-27 | 0.04 USD | -0.03 USD | +233.3% | Beat |
| 2024-08-08 | -0.13 USD | -0.02 USD | -550% | Miss |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
ORGO valuation and analyst view
| Trailing P/E | -16.89 |
|---|---|
| Trailing EPS | -0.00222 USD |
| Price / book | 0.83 |
| Dividend yield | 0.00% |
| Market cap | 0.32B |
| Analyst consensus | Buy (4 buy / 1 hold / 0 sell) |
| Avg price target | 3 USD |
Related research pages
Frequently asked questions
When is Organogenesis Holdings (ORGO)'s next earnings date?
Organogenesis Holdings is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.35 USD and revenue estimate of 0.05B.
Did ORGO beat earnings last quarter?
In its 2026-05-07 report, ORGO posted EPS of -0.37 USD versus a -0.29 USD estimate — a miss of 27.6%.
What is ORGO's earnings track record?
Over the last 5 reported quarters with consensus data, ORGO beat estimates 2 times (40%).
What is ORGO's current P/E ratio and EPS?
ORGO trades at a trailing P/E of -16.89 on trailing EPS of -0.002222274162229441 USD.
What do analysts rate ORGO?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 3 USD.